FCE-26742A MedChemExpress (MCE)

Product Name	(2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide
Synonyms	ralfinamide Safinamide-6 Guadecitabine Sodium (2S)-2-(4-(2-Fluorobenzyloxy)benzylamino)propanamide (S)-2-[[4-[(2-Fluorobenzyl)oxy]benzyl]amino]propanamide (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide
CAS	133865-88-0
EINECS	200-582-5
Chemical Formula	C17H19FN2O2
Molecular Weight	302.34
inchi
Package	10 mM * 1 mL;5 mg;10 mg;50 mg
Price	Get quote
Descriptions	Ralfinamide Ralfinamide MedChemExpress (MCE) HY-101437 133865-88-0 FCE-26742A 99.21% Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Room temperature in continental US Descriptions Ralfinamide Ralfinamide MedChemExpress (MCE) HY-101437 133865-88-0 FCE-26742A 99.21% Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Room temperature in continental US may vary elsewhere. Ralfinamide (FCE-26742A) is an orally available Na+ blocker derived from α-aminoamide, with function of suppressing pain. Ralfinamide (30 mg/kg, 60 mg/kg p.o. twice daily 42 days) treated with Ralfinamide (80 mg/kg p.o. twice daily 7 days) preoperatively suppresses neuropathic pain[1]. Na+channel[1] In Vivo Ralfinamide (30 mg/kg, 60 mg/kg p.o. twice daily 42 days) treated with Ralfinamide (80 mg/kg p.o. twice daily 7 days) preoperatively suppresses neuropathic pain[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: 81 adult male Sprague–Dawley male rats (260–460 g)[1] \| \| \| \| \| \| \| \| \| \| [1]. Zhang SH, et al. Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat. Pain. 2008 Oct 15 139(2):293-305. [Content Brief] [2]. Liang X, et al. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain. Eur J Pharmacol. 2018 Mar 15 823:27-34. [Content Brief]
Last Update	2025-04-01 14:45:47

MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-04-01 14:45:47

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-04-01 14:45:47

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-04-01 14:45:47

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-04-01 14:45:47

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-04-01 14:45:47

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-04-01 14:45:47

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-04-01 14:45:47

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-04-01 14:45:47


Supplier Name	MedChemExpress (MCE)
Contact	sales
Tel	609-228-6898
Mobile	609-228-6898
QQ
Email	sales@medchemexpress.com; tech@medchemexpress.com
Website	https://www.medchemexpress.com/
Wechat

Request for quotation

Supplier Contact